Redefining outcomes of ventricular arrhythmia for SGLT2 inhibitor medication in heart failure patients: a meta-analysis of randomized controlled trials
Miao Lin(Southwest Medical University), Xianhong Ou(Southwest Medical University), Xiaoqiu Tan(Southwest Medical University), Shiyu Zhang(Hainan Medical University), Luo Yang, Chengying Yang(Fuyang Normal University), Lu Zhang(Affiliated Hospital of Southwest Medical University), Qiang Wen(Chinese General Hospital College of Nursing and Liberal Arts), Xinrong Fan(Affiliated Hospital of Southwest Medical University)
Cited by 11
Related Papers
An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including Omicron
|Nature Microbiology|2022|101
Function of BK <sub>Ca</sub> Channels Is Reduced in Human Vascular Smooth Muscle Cells From Han Chinese Patients With Hypertension
|Hypertension|2012|89
A new generation Mpro inhibitor with potent activity against SARS-CoV-2 Omicron variants
|Signal Transduction and Targeted Therapy|2023|82
Principles of Optogenetic Methods and Their Application to Cardiac Experimental Systems
|Frontiers in Physiology|2019|78